hatch-waxman – Duane Morris Life Sciences Law

September 20, 2019September 20, 2019 by Duane Morris

Duane Morris Recognized by LMG Life Sciences Awards for Role in Hatch-Waxman Impact Case of the Year

Duane Morris LLP was honored for its role in a Hatch-Waxman Impact Case of the Year at the Legal Media Group (LMG) Life Sciences Awards 2019. The case was Teva Pharmaceuticals et al v. Sandoz et al. (Fed. Circ. 2018), where the firm represented Amneal.

Duane Morris was also shortlisted as a “Firm to Watch – Financial & Corporate” and partner Anthony J. Fitzpatrick in Boston was named a finalist for “General Patent Litigator of the Year – New England.”

For more information, read the news release.

July 31, 2014September 10, 2014 by Duane Morris

Duane Morris Partner Frederick Ball to Moderate at the FDLI’s Conference, Celebrating the 30th Anniversary of the Hatch-Waxman Amendments: The Past, Present and Future of Generic Drugs

Duane Morris partner Frederick R. Ball will be serving as a moderator on a session titled “The Present Part 2: Generic Industry Challenges and Current Issues” at the Food and Drug Law Institute’s conference. The conference, Celebrating the 30th Anniversary of the Hatch-Waxman Amendments: The Past, Present and Future of Generic Drugs, will take place on September 18, 2014 in Washington, D.C. Mr. Ball’s session will begin at 1:45 p.m.

Continue reading “Duane Morris Partner Frederick Ball to Moderate at the FDLI’s Conference, Celebrating the 30th Anniversary of the Hatch-Waxman Amendments: The Past, Present and Future of Generic Drugs”